PL411211A1 - Application of a teat for suction as the innovative pharmaceutical form - Google Patents

Application of a teat for suction as the innovative pharmaceutical form

Info

Publication number
PL411211A1
PL411211A1 PL411211A PL41121115A PL411211A1 PL 411211 A1 PL411211 A1 PL 411211A1 PL 411211 A PL411211 A PL 411211A PL 41121115 A PL41121115 A PL 41121115A PL 411211 A1 PL411211 A1 PL 411211A1
Authority
PL
Poland
Prior art keywords
teat
pharmaceutical form
suction
application
jelly
Prior art date
Application number
PL411211A
Other languages
Polish (pl)
Inventor
Przemysław Paweł Taciak
Aleksander Paweł Mazurek
Original Assignee
Przemysław Paweł Taciak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Przemysław Paweł Taciak filed Critical Przemysław Paweł Taciak
Priority to PL411211A priority Critical patent/PL411211A1/en
Publication of PL411211A1 publication Critical patent/PL411211A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Przedmiotem wynalazku jest wykorzystanie formy popularnego smoczka dla niemowlaków jako innowacyjnej postaci farmaceutycznej. Wynalazek ma kształt przypominający, lub na pierwszy rzut oka identyczny, w stosunku do tradycyjnego smoczka. Natomiast wykonany jest (jego zasadnicza część - znajdująca się w ustach dziecka) z galaretki w rodzaju żelka (żelatynowej i/lub agarowej i/lub pektywnej i/lub innej). Żelek stanowi bazę dla substancji czynnej. Dzięki zastosowaniu omawianej postaci farmaceutycznej opracowano, jako przykłady wynalazku, preparaty o kontrolowanym uwalnianiu substancji czynnej.The subject of the invention is the use of the popular infant teat form as an innovative pharmaceutical form. The invention has a shape reminiscent of, or at first glance, identical to a traditional teat. However, it is made (its main part - located in the child's mouth) from jelly-like jelly (gelatin and / or agar and / or prospective and / or other). The jelly is the basis for the active substance. By using the pharmaceutical form in question, controlled-release formulations of the active substance have been developed as examples of the invention.

PL411211A 2015-02-09 2015-02-09 Application of a teat for suction as the innovative pharmaceutical form PL411211A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL411211A PL411211A1 (en) 2015-02-09 2015-02-09 Application of a teat for suction as the innovative pharmaceutical form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL411211A PL411211A1 (en) 2015-02-09 2015-02-09 Application of a teat for suction as the innovative pharmaceutical form

Publications (1)

Publication Number Publication Date
PL411211A1 true PL411211A1 (en) 2016-08-16

Family

ID=56617445

Family Applications (1)

Application Number Title Priority Date Filing Date
PL411211A PL411211A1 (en) 2015-02-09 2015-02-09 Application of a teat for suction as the innovative pharmaceutical form

Country Status (1)

Country Link
PL (1) PL411211A1 (en)

Similar Documents

Publication Publication Date Title
CY1124848T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AZD9291
TWD193506S (en) Oral care implement
EA201792592A1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN
EA201792591A1 (en) PHARMACEUTICAL PREPARATIONS
MX2018010032A (en) Il-6 antagonist formulations and uses thereof.
EA202090536A1 (en) CRYSTALLINE FORMS OF 3-SUBSTITUTED 1,2,4-OXADIAZOL
EA201891337A3 (en) PHARMACEUTICAL COMPOSITION FROM NEUROPATHIC PAIN
MA50047A (en) ORAL ADMINISTRATION OF GLP-1 PEPTIDIC ANALOGUES
TWD190452S (en) Oral care implement
EA201990093A1 (en) TWO COMPONENT COMPOSITION
EA201792237A1 (en) PHARMACEUTICAL COMPOSITIONS
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
PL411211A1 (en) Application of a teat for suction as the innovative pharmaceutical form
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
CY1125762T1 (en) NEW BY THE MOUTH PREPARATION VELINOSTATIS
EA201992844A1 (en) NEW ORAL COMPOSITIONS BASED ON BELINOSTAT
EA202091127A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE
TR201716203A1 (en) New umeclidinium formulations.
CN302543979S (en) Toothbrush Sterilizer(SG-106)
BR112018007122A2 (en) nutritional composition selected from infant formula and continuation formula, and nutritional composition for use
UA117489U (en) PHARMACEUTICAL COMPOSITION IN THE OIL FORM WITH ANTI-VIRUS AND IMMUNE MODELING
TH179566A (en) An oral pharmaceutical formulation containing long-acting granules containing tamsulosin. Hydrochloride "
CN302511392S (en) Toy Insects (2)
CN302511389S (en) Toy Insects (1)
MX2014008984A (en) Obtention process and pharmaceutical composition of capsules of fenofibrate as a lipid regulator of oral administration.